Mv Capital Management, Inc. Astrazeneca PLC Transaction History
Mv Capital Management, Inc.
- $889 Million
- Q1 2025
A detailed history of Mv Capital Management, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Mv Capital Management, Inc. holds 117 shares of AZN stock, worth $8,125. This represents 0.0% of its overall portfolio holdings.
Number of Shares
117
Previous 117
-0.0%
Holding current value
$8,125
Previous $7,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,426Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$3.96 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.82 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.47 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.21 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.17 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $215B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...